Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PTGER4 | P35408 | 1/20 | 0.37 |
| ▸ | CYP11B2 | P19099 | 2/20 | 0.36 |
| ▸ | KDM1A | O60341 | 4/20 | 0.35 |
| ▸ | MMP2 | P08253 | 2/20 | 0.34 |
| ▸ | MMP3 | P08254 | 2/20 | 0.34 |
| ▸ | SRC | P12931 | 1/20 | 0.34 |
| ▸ | EGLN1 | Q9GZT9 | 1/20 | 0.34 |
| ▸ | HRH2 | P25021 | 1/20 | 0.33 |
| ▸ | HRH1 | P35367 | 1/20 | 0.33 |
| ▸ | AR | P10275 | 1/20 | 0.33 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.33 |
| ▸ | ATM | Q13315 | 1/20 | 0.33 |
| ▸ | FNTA | P49354 | 1/20 | 0.33 |
| ▸ | FNTB | P49356 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL22298177 | 0.80 | SRC (0.38) | PTGER4SRCARALDH1A1 | |
| SCHEMBL14524914 | 0.78 | AR (0.44) | PTGER4CYP11B2KDM1AMMP3AR | |
| SCHEMBL14525308 | 0.74 | AR (0.38) | PTGER4CYP11B2KDM1AMMP2MMP3 | |
| SCHEMBL16920311 | 0.71 | MMP3 (0.47) | MMP2MMP3 | |
| SCHEMBL16615592 | 0.70 | HRH2 (0.42) | PTGER4CYP11B2KDM1AMMP2MMP3 | |
| SCHEMBL23958923 | 0.70 | MAOB (0.43) | CYP11B2MMP3EGLN1ALDH1A1ATM | |
| SCHEMBL134950 | 0.69 | MAOB (0.47) | CYP11B2 | |
| SCHEMBL14499523 | 0.69 | KDM1A (0.45) | CYP11B2KDM1AARALDH1A1 | |
| SCHEMBL5544383 | 0.69 | STS (0.35) | SRCFNTAFNTB | |
| SCHEMBL16615488 | 0.69 | MMP2 (0.40) | PTGER4CYP11B2KDM1AMMP2MMP3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9500790-B2 | Optical film, circularly polarizing plate, and image display device | Konica Minolta, Inc. (JP) | 2016-11-22 | — | — | US | disclosed |
| US-20150247963-A1 | OPTICAL FILM, CIRCULARLY POLARIZING PLATE, AND IMAGE DISPLAY DEVICE | Konica Minolta, Inc. (JP) | 2015-09-03 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20150247963-A1 | OPTICAL FILM, CIRCULARLY POLARIZING PLATE, AND IMAGE DISPLAY DEVICE | SUN2, HTR3D, CRY1 | PTGER4 1632/4885CYP11B2 2156/4885KDM1A 312/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.